# Ardelyx, Inc. (ARDX)

> Ardelyx, Inc. (ARDX) trades at $2.99 (-2.29%) as of 7:56:24 PM EST on Nov 20, 2026, -6.56% over the past month. Market cap is $751.6M, with 7.5 days to cover in short interest.

Canonical: https://massive.com/quote/ardx
Data as of: 2026-11-21T00:56:24.149Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$2.99** -0.07 (-2.29%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$3.00** +0.01 (+0.33%)
As of 7:56:24 PM EST on Nov 20, 2026 · After hours

## Stock performance

How Ardelyx, Inc. (ARDX) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -2.29% |
| 1W | -3.24% |
| 1M | -6.56% |
| YTD | -48.71% |
| 1Y | -45.64% |
| 52-wk range | $2.80 – $8.40 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for ARDX: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $2.95 – $3.08 |
| Open | $3.01 |
| Prev close | $3.06 |
| Volume | 6.2M |
| Market cap | $751.6M |
| Shares out | 251.37M |

## Valuation and profitability ratios

Valuation and profitability ratios for Ardelyx, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 1.61 |
| P/B | 4.58 |
| P/FCF | — |
| ROE | -33.8% |
| ROA | -9.4% |
| Debt/Equity | 1.54 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[Ardelyx, Inc. (ARDX) insider trading](https://massive.com/quote/ardx/insider-trading.md): open-market Form 4 buys and sells by Ardelyx, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Ardelyx, Inc. has disclosed to the SEC on Form 8-K.

- Nov 3, 2026 · Investor presentation
  “On November 3, 2026, the Company will host a conference call to discuss its financial results for the quarter ended September 30, 2026. A copy of the earnings presentation that will be used during this conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.”
- Aug 17, 2026 · [Executive officer departure](https://massive.com/quote/sec-filings/8-k/executive-departures.md)
  “On August 11, 2026, Eric Foster notified Ardelyx, Inc. (the "Company") of his decision to resign as Chief Commercial Officer of the Company, effective August 28, 2026. Mr. Foster resigned to pursue a new opportunity with a pre-commercial company, and his resignation is not a result of any disagreement with the Company.”
- Aug 6, 2026 · Investor presentation
  “On August 6, 2026, the Company will host a conference call to discuss its financial results for the quarter ended June 30, 2026. A copy of the earnings presentation that will be used during this conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.”
- Jul 2, 2026 · Credit facility draw
  “On June 29, 2026, Ardelyx, Inc. (the "Company") received $50.0 million of funding (the "Term F Loan") pursuant to the loan and security agreement entered into in February 2022 by and between the Company and SLR Investment Corp., as collateral agent (the "Agent") and the lenders listed in the agreement (collectively, the "Lenders"), as amended in August 2022, February 2023, October 2023, October 2024, June 2025 and April 2026 (collectively, the "Loan Agreement").”
- Jun 17, 2026 · Shareholder proposal outcome
  “The Company's stockholders approved, on a non-binding, advisory basis, the Say-On-Pay proposal with 137,617,786 votes for and 9,413,395 votes against. The Company's stockholders also approved, on a non-binding, advisory basis, the frequency of a Say-On-Pay vote occurring every one (1) year with 141,539,889 votes for.”

## ARDX short interest

How heavily ARDX is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 7.5 |
| Short interest | 29.21M |
| Avg volume | 3.88M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## ARDX news

The latest news and headlines about Ardelyx, Inc. (ARDX).

- [Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm](https://www.globenewswire.com/news-release/2026/11/16/3403868/9788/en/bronstein-gewirtz-grossman-llc-urges-ardelyx-inc-investors-to-act-class-action-filed-alleging-investor-harm.html) · GlobeNewswire Inc. · Nov 16, 2026 · negative sentiment
- [ARDX DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - ARDX](https://www.globenewswire.com/news-release/2026/11/16/3403137/673/en/ardx-deadline-tomorrow-rosen-a-leading-law-firm-encourages-ardelyx-inc-investors-to-secure-counsel-before-important-november-16-deadline-in-securities-class-action-ardx.html) · GlobeNewswire Inc. · Nov 15, 2026 · negative sentiment
- [Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm](https://www.globenewswire.com/news-release/2026/11/12/3401943/9788/en/bronstein-gewirtz-grossman-llc-urges-ardelyx-inc-investors-to-act-class-action-filed-alleging-investor-harm.html) · GlobeNewswire Inc. · Nov 12, 2026 · negative sentiment
- [SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Kinross Gold Corporation (NYSE: KGC) — Investors Who Suffered Losses Are Encouraged to Contact the Firm](https://www.globenewswire.com/news-release/2026/11/12/3401945/9788/en/shareholder-alert-bronstein-gewirtz-grossman-llc-announces-class-action-against-kinross-gold-corporation-nyse-kgc-investors-who-suffered-losses-are-encouraged-to-contact-the-firm.html) · GlobeNewswire Inc. · Nov 12, 2026 · negative sentiment
- [DOCS DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS](https://www.globenewswire.com/news-release/2026/11/10/3399128/673/en/docs-deadline-notice-rosen-a-longstanding-law-firm-encourages-doximity-inc-investors-to-secure-counsel-before-important-november-16-deadline-in-securities-class-action-docs.html) · GlobeNewswire Inc. · Nov 9, 2026 · negative sentiment

## About Ardelyx, Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 489 |
| Listed | Jun 19, 2014 |

[Company website](https://www.ardelyx.com)

## FAQ

### What is the Ardelyx, Inc. (ARDX) stock price today?

Ardelyx, Inc. (ARDX) is trading at $2.99 (-2.29% on the day) as of 7:56:24 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Ardelyx, Inc.?

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that…

### What is the short interest in ARDX?

As of Oct 30, 2026, ARDX has 29.21M shares short and 7.5 days to cover.

### What exchange is ARDX listed on?

Ardelyx, Inc. (ARDX) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time ARDX quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ARDX`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Ardelyx, Inc. (ARDX) insider trading](https://massive.com/quote/ardx/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
